HomeASRT • NASDAQ
add
Assertio Holdings Inc
Nakaraang pagsara
$0.84
Sakop ng araw
$0.80 - $0.84
Sakop ng taon
$0.74 - $1.80
Market cap
76.71M USD
Average na Volume
809.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 29.20M | -18.03% |
Gastos sa pagpapatakbo | 24.40M | -18.13% |
Net na kita | -2.92M | 98.96% |
Net profit margin | -10.00 | 98.73% |
Kita sa bawat share | 0.03 | 200.00% |
EBITDA | 3.96M | -56.54% |
Aktuwal na % ng binabayarang buwis | -1.53% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 88.58M | 15.21% |
Kabuuang asset | 276.00M | -27.37% |
Kabuuang sagutin | 145.48M | -22.27% |
Kabuuang equity | 130.52M | — |
Natitirang share | 95.48M | — |
Presyo para makapag-book | 0.61 | — |
Return on assets | -2.47% | — |
Return on capital | -4.00% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.92M | 98.96% |
Cash mula sa mga operasyon | -35.00K | -101.36% |
Cash mula sa pag-invest | -6.71M | -261.90% |
Cash mula sa financing | -10.00K | 0.00% |
Net change in cash | -6.75M | -200.61% |
Malayang cash flow | 900.88K | 99.64% |
Tungkol
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Itinatag
1995
Headquarters
Website
Mga Empleyado
53
